Dyslipidaemia in South Africa

Cardiovascular Journal of South Africa

Volumn 15, Issue 3, 2004, Pages 105-106

  Marais, A David ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B; APOLIPOPROTEIN C2; APOLIPOPROTEIN E; CHOLESTEROL; CHYLOMICRON; HIGH DENSITY LIPOPROTEIN; LIPOPROTEIN; LIPOPROTEIN LIPASE; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CORRELATION ANALYSIS; DYSLIPIDEMIA; DYSLIPOPROTEINEMIA; EARLY DIAGNOSIS; EDITORIAL; FAMILIAL HYPERCHOLESTEROLEMIA; GENE MUTATION; HERITABILITY; HUMAN; HYPERLIPOPROTEINEMIA TYPE 1; HYPERTENSION; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; LIFESTYLE; LIPID STORAGE; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; OBESITY; PATIENT CARE; PENETRANCE; PHENOTYPE; PREVALENCE; SOUTH AFRICA; TRIACYLGLYCEROL BLOOD LEVEL;

ARTERIOSCLEROSIS; HUMANS; HYPERLIPIDEMIAS; HYPERLIPOPROTEINEMIA TYPE II; LIPOPROTEINS; SOUTH AFRICA;

EID: 4043094783     PISSN: 10159657     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (20)

1. Berger GM, Marais AD. Diagnosis, management and prevention of the common dyslipidaemias in South Africa - Clinical Guideline, 2000. S Afr Med J 2000; 90: 164-178.
2. Marais AD. Lipoprotein metabolism and its derangements. Cont Med Educ 2003; 21: 384-388.
3. Rossouw JE, Jooste PL, Steyn K, Benade AJS. Serum total and high density lipoprotein cholesterol - reference values obtained in the Coronary Risk Factor Study baseline survey. S Afr Med J 1985; 67: 533-538.
4. Steyn K, Benade AJS, Langenhoven ML, Joubert G, Rossouw JE. Hypercholesterolaemia in the coloured population of the Cape Peninsula (CRISIC study). S Afr Med J 1987; 71: 483-486.
5. Steyn K, Jooste PL, Bourne L, et al. Risk factors for coronary heart disease in the black population of the Cape Peninsula. The BRISK study. S Afr Med J 1991; 79: 480-485.
6. Seedat YK, Mayet FGH, Latiff GH, Joubert G. Risk factors and coronary heart disease in Durban blacks - the missing links. S Afr Med J 1992; 82: 251-256.
7. Oosthuizen W, Vorster HH, Kruger A, Venter CS, Kruger HS, de Ridder JH. Impact of urbanisation on serum lipid profiles - the THUSA study. S Afr Med J 2002; 92: 723-728.
8. Seedat YK, Mayet FGH, Khan S, Somers SR, Joubert G. Risk factors for coronary heart disease in the Indians of Durban. S Afr Med J 1990; 78: 446-454.
9. Walker ARP, Adam A, Küstner HJV. Changes in total death rate and in ischaemic heart disease death rate in interethnic South African populations. 1978-1989. S Afr Med J 1993; 83: 602-605.
10. Murray CJL, Lopez AP. Alternative projections of mortality and disability by cause 1990-2020: global burden of disease study. Lancet 1997; 349: 1498-1504.
11. Wilson PWF, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation 1988; 97: 1837-1847.
12. Seftel HC, Baker SG, Sandler MJ, Forman MB, Joffe BI, Mendelsohn D, Jenkins T, Mieny CJ. A host of hypercholesterolaemic homozygotes in South Africa. Brit Med J 1980; 281: 633-636.
13. Gevers W. Three mutations that cause familial hypercholesterolaemia in Afrikaners identified - a milestone in South African medicine. S Afr Med J 1989; 76: 393-394.
14. Steyn K, Goldberg YP, Kotze MJ, Steyn M, Swanepoel AS, Fourie JM, et al. Estimation of the prevalence of familial hypercholesterolaemia in a rural Afrikaner community by direct screening for three Afrikaner founder low density lipoprotein receptor gene mutations. Hum Genet 1996; 98: 479-484.
15. Rubinsztein DC, Coetzee GA, Marais AD, Leitersdorf E, Szeftel HC, van der Westhuyzen DR. Identification and properties of the proline664_leucine mutant LDL receptor in South Africans of Indian origin. J Lipid Res 1992; 33: 1647-1655.
16. Vergotine J, Thiart R, Kotze MJ. Clinical versus molecular diagnosis of heterozygous familial hypercholesterolaemia in the diverse South African population. S Afr Med J 2001; 91: 1053-1059.
17. Marais AP, Berger GMB. A diversity of genetic hyperlipoproteinaemias in black patients. S Afr Med J 1986; 70: 583-587.
18. Marais AD, Firth JC, Rose AG, Berger GMB. Fatal outcome of homozygous familial hypercholesterolaemia in a black patient. S Afr Med J 1990; 77: 588-590.
19. de Villiers WJS, van der Westhuyzen DR, Coetzee GA, Henderson HE, Marais AD. The apolipoprotein E2 (arg145cys) mutation causes autosomal dominant type III hyperlipoproteinemia with incomplete penetrance. Arterioscler Thromb Vasc Biol 1997; 17: 865-872.
20. Marais AD, Benatar SR. Planning rational management of chronic diseases: lessons from a lipid clinic. S Afr Med J 1995; 85: 340-341.